DE69631774D1 - 2,3-dioxo-1,2,3,4-tetrahydro-chinoxalin derivate - Google Patents
2,3-dioxo-1,2,3,4-tetrahydro-chinoxalin derivateInfo
- Publication number
- DE69631774D1 DE69631774D1 DE69631774T DE69631774T DE69631774D1 DE 69631774 D1 DE69631774 D1 DE 69631774D1 DE 69631774 T DE69631774 T DE 69631774T DE 69631774 T DE69631774 T DE 69631774T DE 69631774 D1 DE69631774 D1 DE 69631774D1
- Authority
- DE
- Germany
- Prior art keywords
- dioxo
- tetrahydro
- chinoxaline
- derivatives
- chinoxaline derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- ABJFBJGGLJVMAQ-UHFFFAOYSA-N 1,4-dihydroquinoxaline-2,3-dione Chemical class C1=CC=C2NC(=O)C(=O)NC2=C1 ABJFBJGGLJVMAQ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH247995 | 1995-08-31 | ||
| CH247995 | 1995-08-31 | ||
| CH273495 | 1995-09-27 | ||
| CH273495 | 1995-09-27 | ||
| CH274795 | 1995-09-28 | ||
| CH274795 | 1995-09-28 | ||
| CH121396 | 1996-05-10 | ||
| CH121396 | 1996-05-10 | ||
| CH163096 | 1996-06-28 | ||
| CH163096 | 1996-06-28 | ||
| PCT/EP1996/003644 WO1997008155A1 (en) | 1995-08-31 | 1996-08-19 | Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69631774D1 true DE69631774D1 (de) | 2004-04-08 |
| DE69631774T2 DE69631774T2 (de) | 2005-01-13 |
Family
ID=27508939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69631774T Expired - Lifetime DE69631774T2 (de) | 1995-08-31 | 1996-08-19 | 2,3-dioxo-1,2,3,4-tetrahydro-chinoxalin derivate |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6080743A (de) |
| EP (1) | EP0853617B1 (de) |
| JP (1) | JP3159711B2 (de) |
| KR (1) | KR100462337B1 (de) |
| CN (1) | CN1137886C (de) |
| AR (1) | AR005229A1 (de) |
| AT (1) | ATE260902T1 (de) |
| AU (1) | AU705871B2 (de) |
| BR (1) | BRPI9603626B8 (de) |
| CA (1) | CA2227851C (de) |
| CZ (1) | CZ56298A3 (de) |
| DE (1) | DE69631774T2 (de) |
| DK (1) | DK0853617T3 (de) |
| ES (1) | ES2217324T3 (de) |
| HU (1) | HUP9801676A3 (de) |
| IL (1) | IL122987A (de) |
| MY (1) | MY132385A (de) |
| NO (1) | NO310236B1 (de) |
| NZ (1) | NZ316497A (de) |
| PL (1) | PL189637B1 (de) |
| PT (1) | PT853617E (de) |
| SI (1) | SI0853617T1 (de) |
| SK (1) | SK25298A3 (de) |
| TR (1) | TR199800349T2 (de) |
| WO (1) | WO1997008155A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3133697A (en) * | 1996-06-05 | 1998-01-05 | Warner-Lambert Company | Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| ES2264171T3 (es) * | 1996-10-24 | 2006-12-16 | Novartis Ag | Acidos aminoalcanofosfonicos sustituidos. |
| ZA9710553B (en) * | 1996-11-25 | 1998-06-10 | Warner Lambert Co | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists. |
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US6172065B1 (en) | 1997-03-04 | 2001-01-09 | Warner-Lambert Company | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6340758B1 (en) | 1997-05-16 | 2002-01-22 | Warner-Lambert Company | Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
| US6096744A (en) * | 1998-05-04 | 2000-08-01 | Warner-Lambert Company | Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6677332B1 (en) | 1999-05-25 | 2004-01-13 | Sepracor, Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US7361666B2 (en) | 1999-05-25 | 2008-04-22 | Sepracor, Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US6635661B2 (en) | 2000-05-25 | 2003-10-21 | Sepracor Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| AU2001216218A1 (en) * | 2000-05-25 | 2001-12-11 | Sepracor, Inc. | Heterocyclic analgesic compounds and method of use thereof |
| EP1436258A4 (de) * | 2001-03-08 | 2005-03-23 | Univ Emory | Ph-wert-abhängige nmda-rezeptorantagonisten |
| TW200403066A (en) * | 2002-04-30 | 2004-03-01 | Novartis Ag | New uses of substituted aminoalkanephosphonic acids |
| GB0310868D0 (en) * | 2003-05-12 | 2003-06-18 | Novartis Ag | Organic compounds |
| US7524837B2 (en) * | 2003-05-12 | 2009-04-28 | Janssen Pharmaceutica N.V. | Benzotriazapinone salts and methods for using same |
| MXPA06003578A (es) * | 2003-09-30 | 2006-08-31 | Johnson & Johnson | Compuestos de quinoxalina. |
| US20060020029A1 (en) * | 2004-07-02 | 2006-01-26 | Shimasaki Craig D | Pharmaceutical compositions from ethnobotanicals |
| UA95788C2 (en) * | 2005-12-15 | 2011-09-12 | Ф. Хоффманн-Ля Рош Аг | Fused pyrrole derivatives |
| JP2010532382A (ja) * | 2007-06-29 | 2010-10-07 | エモリー・ユニバーシテイ | 神経保護のためのnmda受容体拮抗薬 |
| CN102906085A (zh) * | 2010-05-20 | 2013-01-30 | 诺瓦提斯公司 | 2,4-二氧代-1,4-二氢-2h-喹唑啉-3-基-磺酰胺衍生物 |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| JO3225B1 (ar) * | 2012-11-27 | 2018-03-08 | Lilly Co Eli | 6-((s)-1-{1-[5-(2-هيدروكسي-إيثوكسي)-بيريدين-2-يل]-1h-بيرازول-3-يل}إيثيل)-3h-1 ، 3-بنزو ثيازول-2- أون باعتباره مضاد مستقبل ampa يعتمد على tarp- جاما 8 |
| CN103435561B (zh) * | 2013-08-19 | 2016-08-10 | 上海交通大学 | 一种新型d-氨基酸氧化酶抑制剂及其制备和应用 |
| EP3573960B1 (de) * | 2017-01-27 | 2023-08-16 | Genfit | N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2h-1,4-benzoxazin-7-yl)acetamid-derivate und verwandte verbindungen als ror-gamma modulatoren zur behandlung von autoimmunerkrankungen |
| MX393950B (es) | 2017-06-12 | 2025-03-24 | Glytech Llc | Composicion y metodo para el tratamiento de la depresion y psicosis en humanos |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4156734A (en) * | 1976-02-13 | 1979-05-29 | Merck & Co., Inc. | Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid |
| CA2002864C (en) * | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
| WO1991001724A1 (en) * | 1989-07-27 | 1991-02-21 | G.D. Searle & Co. | Renal-selective prodrugs for the treatment of hypertension |
| US5631373A (en) * | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| GB9418443D0 (en) * | 1994-09-13 | 1994-11-02 | Pfizer Ltd | Therapeutic agents |
| GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
-
1996
- 1996-08-12 MY MYPI96003300A patent/MY132385A/en unknown
- 1996-08-19 CN CNB961965819A patent/CN1137886C/zh not_active Expired - Fee Related
- 1996-08-19 HU HU9801676A patent/HUP9801676A3/hu unknown
- 1996-08-19 CZ CZ98562A patent/CZ56298A3/cs unknown
- 1996-08-19 PL PL96324992A patent/PL189637B1/pl not_active IP Right Cessation
- 1996-08-19 AT AT96929275T patent/ATE260902T1/de active
- 1996-08-19 TR TR1998/00349T patent/TR199800349T2/xx unknown
- 1996-08-19 DE DE69631774T patent/DE69631774T2/de not_active Expired - Lifetime
- 1996-08-19 PT PT96929275T patent/PT853617E/pt unknown
- 1996-08-19 US US09/029,525 patent/US6080743A/en not_active Expired - Lifetime
- 1996-08-19 JP JP50980197A patent/JP3159711B2/ja not_active Expired - Fee Related
- 1996-08-19 SK SK252-98A patent/SK25298A3/sk unknown
- 1996-08-19 SI SI9630678T patent/SI0853617T1/xx unknown
- 1996-08-19 AU AU68742/96A patent/AU705871B2/en not_active Ceased
- 1996-08-19 CA CA002227851A patent/CA2227851C/en not_active Expired - Fee Related
- 1996-08-19 WO PCT/EP1996/003644 patent/WO1997008155A1/en not_active Ceased
- 1996-08-19 NZ NZ316497A patent/NZ316497A/xx unknown
- 1996-08-19 IL IL12298796A patent/IL122987A/en not_active IP Right Cessation
- 1996-08-19 KR KR10-1998-0701511A patent/KR100462337B1/ko not_active Expired - Fee Related
- 1996-08-19 DK DK96929275T patent/DK0853617T3/da active
- 1996-08-19 ES ES96929275T patent/ES2217324T3/es not_active Expired - Lifetime
- 1996-08-19 EP EP96929275A patent/EP0853617B1/de not_active Expired - Lifetime
- 1996-08-30 AR ARP960104160A patent/AR005229A1/es active IP Right Grant
- 1996-08-30 BR BRPI9603626A patent/BRPI9603626B8/pt not_active IP Right Cessation
-
1998
- 1998-02-26 NO NO19980814A patent/NO310236B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69631774D1 (de) | 2,3-dioxo-1,2,3,4-tetrahydro-chinoxalin derivate | |
| DE69613368D1 (de) | Chinazolin derivate | |
| DE69613369D1 (de) | Chinazolin derivate | |
| DE69613367D1 (de) | Chinazolin derivate | |
| ATE264327T1 (de) | Substituierte 6,6-heterobicyclische derivate | |
| ATE228510T1 (de) | Substituierte 1,2,3,4-tetrahydronaphthalin derivate | |
| ATE446955T1 (de) | Chinazolinone derivate | |
| DE122004000018I1 (de) | 4"-Substitutierte-9-Deoxo-9A-Aza-9A-Homoerythromycin a Derivate. | |
| DE69706292D1 (de) | Chinazoline derivate | |
| DE69736711D1 (de) | Substituierte 6,5-heterobicyclische-derivate | |
| MA23780A1 (fr) | Quinazolinones 2, 8 disubstitues | |
| ATE314387T1 (de) | Dolastatin 15 derivate | |
| DE69618634D1 (de) | 1,4-benzodioxin-derivate | |
| FI952424L (fi) | 11,21-bisfenyyli-19-norpregaanijohdannaisia | |
| ATE231847T1 (de) | Substituierte 1,2,3,4- tetrahydronaphthalinderivate | |
| ATE277917T1 (de) | Alkylaminobenzothiazole und -benzoxazole derivate | |
| PT921125E (pt) | Derivados de 1,38-triaza-espiro 4,5 decan-4-ona | |
| TR199800988A3 (tr) | 5' Deoksi-Sitidin türevleri. | |
| BR9609884A (pt) | N-aril- 1,2,4-triazolin-5-onas | |
| DE69600292D1 (de) | Cyclodextrin Derivate | |
| DE69611758D1 (de) | N-1-carbocylalkyl derivate von lsd | |
| ATE241599T1 (de) | 25-hydroxy-16-ene-26,27-bishome-cholecalcerifer l derivate | |
| DE69622415D1 (de) | 12H-Dibenzo[d,g][1,3]dioxocin Derivate | |
| ATE240941T1 (de) | 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate | |
| DE69635901D1 (de) | Polycyclische derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |